Clinical Trials Sponsored by Statens Serum Institut

Total 2530 results

Statens Serum Institut

Completed

A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI

Tuberculosis

South Africa
Statens Serum Institut

Completed

Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C-Tb vs Tuberculin PPD RT23 SSI

Tuberculosis

Spain
Statens Serum Institut

Completed

Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration

Tuberculosis

Denmark
Statens Serum Institut

Completed

A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis(TB) Subunit Vaccine (THYB-01)

Tuberculosis

Netherlands
Statens Serum Institut

Completed

A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG (TESEC-03)

Tuberculosis

United Kingdom
Statens Serum Institut

Completed

A Safety and Immunogenicity Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31) (THYB-03)

Tuberculosis
Statens Serum Institut

Completed

Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses (TESEC-07)

Tuberculosis

South Africa
Statens Serum Institut

Completed

Immunogenicity and Safety of Tetanus, Diphtheria and Mono Component Acellular Pertussis (TdaP) Vaccine in Comparison to Tetanus and Diphtheria (Td) Vaccine When Given as Booster Vaccinations to Adults

Healthy

Denmark
Statens Serum Institut

Completed

A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB) (TESEC-04)

Tuberculosis

South Africa
Statens Serum Institut

Completed

Treatment Study of Metronidazole to Treat Dientamoebiasis in Children (DFPT)

Dientamoebiasis

Denmark
Statens Serum Institut

Completed

A Safety and Dose Finding Trial of C-Tb, When Given to Adult Patients Recently Diagnosed With Active Tuberculosis (TESEC-02)

Tuberculosis

United Kingdom
Statens Serum Institut

Completed

Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers

Tuberculosis

Netherlands
Statens Serum Institut

Completed

Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine

Active Immunization

Poland
Statens Serum Institut

Completed

A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive Volunteers (THYB-02)

Tuberculosis

Netherlands
Aeras
Statens Serum Institut

Completed

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404) (C-011-404)

Tuberculosis

South Africa
Aeras
Statens Serum Institut

Completed

A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)

Latent Tuberculosis | Latent Tuberculosis Bacteriology and Histology Unknown

South Africa
Aeras
Statens Serum Institut

Completed

Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis

Latent Tuberculosis | Latent Tuberculosis Bacteriology and Histology Unknown

South Africa
Aeras
Statens Serum Institut

Completed

A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection

Tuberculosis

Sweden
Aeras
Statens Serum Institut

Completed

A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB (C-037-456)

Tuberculosis

South Africa
Aeras
Statens Serum Institut

Completed

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults

Tuberculosis

Finland
Rigshospitalet, Denmark
Statens Serum Institut

Completed

Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection

Neonatal Infection | Viral Infection | Neonatal Sepsis | Neonatal Death | Herpes Simplex Virus Infection | Newborn; Infection | Neonatal Herpes Simplex Infection | Neonatal HSV Infection

Denmark
Naestved Hospital
Statens Serum Institut

Completed

Plasma Transfusion in Major Vascular Surgery

Arterial Occlusive Diseases | Aortic Aneurysm, Abdominal

Denmark
Statens Serum Institut
Imperial College London

Completed

Safety and Immunogenicity of a Chlamydia Vaccine CTH522 (CHLM-02)

Trachoma

United Kingdom
Bandim Health Project
Statens Serum Institut

Completed

Trial of Two Strains of BCG (BCGSTRAIN)

Morbidity | Bacille Calmette-Guérin

Guinea-Bissau
Aarhus University Hospital
Statens Serum Institut

Completed

Cohabitation Patterns and Incidence of Known and Suspected Sexually Transmitted Diseases

Sexually Transmitted Diseases | Cohabitation Patterns
University of Aarhus
Statens Serum Institut

Completed

Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar (FGS/MGS/STI)

Sexually Transmitted Infections | Schistosoma Haematobium

Madagascar
Statens Serum Institut
Imperial College London

Completed

Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years

Chlamydia Trachomatis

United Kingdom
Statens Serum Institut
Aarhus University Hospital Skejby

Active, not recruiting

Infection and Adverse Pregnancy Outcome

Preterm Birth

Denmark
Ostergotland County Council, Sweden
Statens Serum Institut

Unknown

Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced

Chlamydia Trachomatis | Cervicitis | Urethritis | Genital Mycoplasma Infection

Sweden
Nordsjaellands Hospital
Rigshospitalet, Denmark; Statens Serum Institut

Active, not recruiting

Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization (COVISERA)

COVID-19 | COVID-19 Pneumonia

Denmark
Gorm Greisen
Statens Serum Institut

Completed

Feeding Tube Practices and Colonization of the Preterm Stomach in the First Week of Life

Preterm Birth

Denmark
Statens Serum Institut
Hvidovre University Hospital; Herlev Hospital

Completed

Pneumococcal Vaccination of Crohn Patients (PneuVAC)

Crohns Disease

Denmark
Radboud University Medical Center
Novavax; Statens Serum Institut

Completed

Safety and Efficacy of R0.6C Vaccine (STOP-TRANS)

Malaria | Malaria,Falciparum

Netherlands
Statens Serum Institut
Rigshospitalet, Denmark; Hvidovre University Hospital

Completed

Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection (HIVDCVac)

HIV Infections

Denmark
University Hospital Bispebjerg and Frederiksberg
Statens Serum Institut

Recruiting

Hand Eczema in the Health Care Sector

Hand Eczema

Denmark
Peter Humaidan
Statens Serum Institut

Completed

The Temporo-spatial Dynamics of Genital Tract Microbiota

Infertility, Female

Denmark
Tejs Ehlers Klug
Statens Serum Institut

Unknown

Microbiology of Severe Acute Tonsillitis, Peritonsillar Cellulitis, and Infectious Mononucleosis

Acute Tonsillitis | Infectious Mononucleosis | Peritonsillar Cellulitis

Denmark
Hvidovre University Hospital
Aarhus University Hospital; Statens Serum Institut

Completed

Adipocytokines and Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome
Hvidovre University Hospital
University of Copenhagen; Statens Serum Institut

Completed

Effect of Probiotics (Vivomixx®) on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their Newborn (POP)

Obesity | Pregnancy | Gestational Diabetes Mellitus

Denmark
Zealand University Hospital
University of Copenhagen; Statens Serum Institut

Completed

Diagnostic Strategies in Patients Suspected of Irritable Bowel Syndrome

Irritable Bowel Syndrome

Denmark
Bandim Health Project
World Health Organization; Statens Serum Institut

Completed

Improved Management and in-Hospital Mortality (MTV)

Mortality | Malaria

Guinea-Bissau
Swedish Institute for Infectious Disease Control
MCM Vaccines B.V.; Statens Serum Institut

Unknown

An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster (Tdap Booster)

Pertussis | Tetanus | Diphtheria

Sweden
Copenhagen University Hospital, Hvidovre
Aarhus University Hospital; Statens Serum Institut

Completed

Adipose Expression of Leptin, Adiponectin and IL-6 and Plasma Levels of Adipocytokines in Women With and Without Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome

Denmark
Tor Biering-Sørensen
Statens Serum Institut

Active, not recruiting

Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Older Adults (NUDGE-FLU-2)

Influenza | Behavior and Behavior Mechanisms

Denmark
Tor Biering-Sørensen
Statens Serum Institut

Active, not recruiting

Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease

Influenza | Behavior and Behavior Mechanisms

Denmark
London School of Hygiene and Tropical Medicine
Statens Serum Institut

Completed

Evaluation of Local Mechanisms for Staff Motivation to Reduce Hospital Mortality

Malaria | Hospital Mortality

Guinea-Bissau
Statens Serum Institut
University of Copenhagen; Glostrup University Hospital, Copenhagen

Completed

Infectious Causes of Uveitis

Uveitis

Denmark
Tor Biering-Sørensen
Sanofi; Statens Serum Institut

Recruiting

A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults (DANFLU-2)

Influenza

Denmark
Rigshospitalet, Denmark
Testcenter Danmark, Statens Serum Institut; Copenhagen Emergency Medical Services

Completed

Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test

Covid19 | SARS-CoV-2 | Rapid Antigen Test

Denmark
St George's, University of London
King's College London; Statens Serum Institut

Not yet recruiting

The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study (LISA)

Bacterial Vaginosis | Candida Vaginal

United Kingdom

Clinical Trials Sponsored by Statens Serum Institut

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations